全文获取类型
收费全文 | 30142篇 |
免费 | 1610篇 |
国内免费 | 93篇 |
专业分类
耳鼻咽喉 | 416篇 |
儿科学 | 2227篇 |
妇产科学 | 686篇 |
基础医学 | 3304篇 |
口腔科学 | 596篇 |
临床医学 | 1859篇 |
内科学 | 5897篇 |
皮肤病学 | 1043篇 |
神经病学 | 1357篇 |
特种医学 | 1067篇 |
外科学 | 4867篇 |
综合类 | 976篇 |
一般理论 | 11篇 |
预防医学 | 1542篇 |
眼科学 | 1357篇 |
药学 | 2388篇 |
中国医学 | 167篇 |
肿瘤学 | 2085篇 |
出版年
2023年 | 161篇 |
2022年 | 175篇 |
2021年 | 840篇 |
2020年 | 491篇 |
2019年 | 612篇 |
2018年 | 889篇 |
2017年 | 572篇 |
2016年 | 788篇 |
2015年 | 712篇 |
2014年 | 1191篇 |
2013年 | 1354篇 |
2012年 | 1957篇 |
2011年 | 2091篇 |
2010年 | 1139篇 |
2009年 | 895篇 |
2008年 | 1549篇 |
2007年 | 1614篇 |
2006年 | 1426篇 |
2005年 | 1287篇 |
2004年 | 1195篇 |
2003年 | 1087篇 |
2002年 | 1011篇 |
2001年 | 751篇 |
2000年 | 696篇 |
1999年 | 622篇 |
1998年 | 272篇 |
1997年 | 207篇 |
1996年 | 149篇 |
1995年 | 151篇 |
1994年 | 129篇 |
1993年 | 145篇 |
1992年 | 358篇 |
1991年 | 397篇 |
1990年 | 346篇 |
1989年 | 364篇 |
1988年 | 314篇 |
1987年 | 280篇 |
1986年 | 270篇 |
1985年 | 286篇 |
1984年 | 225篇 |
1983年 | 184篇 |
1979年 | 242篇 |
1978年 | 157篇 |
1977年 | 152篇 |
1976年 | 132篇 |
1975年 | 163篇 |
1974年 | 158篇 |
1973年 | 177篇 |
1972年 | 141篇 |
1971年 | 124篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
Apoorva Challa Neeraj Mahajan Seema Sood Arti Kapil Bimal Kumar Das Vishnubhatla Sreenivas Somesh Gupta 《Indian journal of medical microbiology》2022,40(3):433-435
Treatment guidelines for management of uncomplicated gonorrhoeae have been recently modified owing to alarming upsurge in azithromycin resistance. This study investigated the prevalence and genetic determinants of gonococcal azithromycin resistance in India. Four (5.7%) of 70 gonococcal isolates were resistant to azithromycin. Of 16 isolates investigated for molecular mechanisms of resistance, 13 (81.3%) and 6 (37.5%) isolates exhibited mutations in coding and promoter regions of mtrR gene, respectively. However, ermA, ermB and ermC genes or mutations in rrl gene were absent in all isolates. Azithromycin resistance is low in India posing no immediate threat to use of dual-therapy for syndromic management. 相似文献
2.
3.
Samir Gupta MD MDCS AGAF Balambal Bharti MBBS MPH PhD Dennis J. Ahnen MD Daniel D. Buchanan PhD Iona C. Cheng PhD MPH Michelle Cotterchio PhD Jane C. Figueiredo PhD Steven J. Gallinger MD MSc Robert W. Haile DrPH MPH Mark A. Jenkins PhD Noralane M. Lindor MD Finlay A. Macrae MD AGAF Loïc Le Marchand MD PhD Polly A. Newcomb PhD MPH Stephen N. Thibodeau PhD Aung Ko Win MBBS MPH PhD Maria Elena Martinez PhD 《Cancer》2020,126(13):3013-3020
4.
Gupta Archana A. Mammo Danny A. Page Michael A. 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2020,258(1):167-173
Graefe's Archive for Clinical and Experimental Ophthalmology - To evaluate the long-term safety and efficacy of intrastromal bevacizumab for treatment of deep corneal neovascularization in... 相似文献
5.
6.
7.
Uday Yanamandra Prateek Deo Kamal Kant Sahu Ram Vasudevan Nampoothiri Nalini Gupta Anusree Prabhakaran Deb Prasad Dhibhar Alka Khadwal Gaurav Prakash Man Upadesh Singh Sachdeva Deepesh Lad Neelam Varma Subhash Varma Pankaj Malhotra 《Clinical Lymphoma, Myeloma & Leukemia》2019,19(3):183-189.e1
Background
Multiple myeloma (MM) is a hematologic malignancy of plasma cell origin. MM primarily affects bone marrow, but extramedullary sites can also be involved. Myelomatous pleural effusion (MPE) is an atypical and rare complication of MM. We aimed to systematically study the incidence and clinicopathologic profile of patients with MPE in a real-world setting.Patients and Methods
In this retrospective study, 415 consecutive patients with MM managed at a tertiary care center in North India during a study period of January 1, 2010 to December 31, 2015 were evaluated for MPE. The patients with MPE were analyzed for their clinical profile, diagnosis, treatment, and outcomes.Results
Of these 415 patients, 11 (2.65%) patients had MPE. The median age of the study population was 50 years with male preponderance. The majority of these patients had immunoglobin (Ig)G Kappa disease. All patients had higher than International Staging System stage I disease. MPE was a presenting feature at MM diagnosis in 45.45% (n = 5) of the patients, whereas the rest developed MPE during follow-up. MPE presented predominantly (81.8%) as a unilateral effusion. Concurrent extramedullary involvement at other site was seen in 45.45% (n = 5), with 3 (27%) patients having concurrent myelomatous ascites. Six of these were managed aggressively, whereas 5 patients opted for palliation. The outcomes were dismal (90.9% mortality), with a median survival of 2.47 months.Conclusion
MPE is a rare entity, and positive outcomes of therapy remain low with dismal prognosis. 相似文献8.
9.
Walid K. Abu Saleh Phillip Mason Odeaa Al Jabbari Hany Samir Brian A. Bruckner 《Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital》2015,42(6):569-571
The Impella 5.0, a percutaneously inserted left ventricular assist device, has been used to support patients who have severe heart failure or who are undergoing high-risk percutaneous coronary intervention. We report our surgical placement of the Impella 5.0, through a graft sewn to the aorta, to unload the left ventricle of a 59-year-old man who was undergoing venoarterial extracorporeal membrane oxygenation for postcardiotomy shock. The patient underwent successful placement of a long-term left ventricular assist device before his discharge from the hospital. The versatility of the Impella 5.0 is exemplified in this patient who was successfully bridged to long-term support. 相似文献
10.
Correa Alec Reginald Errol Mishra Puneeta Kabra Madhulika Gupta Neerja 《Indian journal of pediatrics》2020,87(3):175-178
Indian Journal of Pediatrics - To report a phenotypic series of eight patients of Beckwith-Wiedemann Syndrome (BWS) with abnormalities of 11p15.5 region to highlight the spectrum of phenotypic... 相似文献